VLPs Based Vaccine for 2019-nCoV

$ (USD)

0 Comentarios

  

Publicado Por BellaSmith1

•  EstadoEn stock
•  TipoNuevo

Emerging infectious diseases are a major threat to human health. In the past 20 years, the epidemics caused by severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and Ebola virus have caused significant mortality and economic losses. Therefore, it is very important to prevent the spread of new viruses. The most effective way to prevent this viral disease is vaccination. Creative Biolabs proposed a virus like particle (VLP)-based vaccine development service to combat the novel coronavirus (SARS-CoV-2) in China in December 2019. VLPs Based Vaccine for 2019-nCoV https://sars-cov-2.creative-bi....olabs.com/virus-like